Planta Med 2015; 81(12/13): 1190-1197
DOI: 10.1055/s-0035-1546126
Analytical Studies
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

Quantification of Bufadienolides in Bryophyllum pinnatum Leaves and Manufactured Products by UHPLC-ESIMS/MS[*]

Mouhssin Oufir
1   Department of Pharmaceutical Sciences, Division of Pharmaceutical Biology, University of Basel, Basel, Switzerland
,
Christina Seiler
1   Department of Pharmaceutical Sciences, Division of Pharmaceutical Biology, University of Basel, Basel, Switzerland
,
Manon Gerodetti
1   Department of Pharmaceutical Sciences, Division of Pharmaceutical Biology, University of Basel, Basel, Switzerland
,
Julia Gerber
1   Department of Pharmaceutical Sciences, Division of Pharmaceutical Biology, University of Basel, Basel, Switzerland
,
Karin Fürer
1   Department of Pharmaceutical Sciences, Division of Pharmaceutical Biology, University of Basel, Basel, Switzerland
2   Department of Obstetrics, University Hospital Zurich, Zürich, Switzerland
,
Monica Mennet-von Eiff
3   Weleda AG, Arlesheim, Switzerland
,
Siegward-M. Elsas
4   Research Department, Klinik Arlesheim AG, Arlesheim, Switzerland
5   Department of Medicine, Chair for Theory of Medicine, Integrative and Anthroposophic Medicine, University Witten/Herdecke, Herdecke, Germany
,
Rudolf Brenneisen
6   Department of Clinical Research, University of Bern, Bern, Switzerland
,
Ursula von Mandach
2   Department of Obstetrics, University Hospital Zurich, Zürich, Switzerland
,
Matthias Hamburger
1   Department of Pharmaceutical Sciences, Division of Pharmaceutical Biology, University of Basel, Basel, Switzerland
,
Olivier Potterat
1   Department of Pharmaceutical Sciences, Division of Pharmaceutical Biology, University of Basel, Basel, Switzerland
› Author Affiliations
Further Information

Publication History

received 17 March 2015
revised 24 April 2015

accepted 28 April 2015

Publication Date:
01 July 2015 (online)

Abstract

A quantitative assay for determination of the main bufadienolides bersaldegenin-1-acetate (1), bersaldegenin-3-acetate (2), bryophyllin A (3), and bersaldegenin-1,3,5-orthoacetate (4) in Bryophyllum pinnatum leaves and manufactured products was developed and validated. The assay involved extraction by pressurised liquid extraction, followed by quantification by ultrahigh performance liquid chromatography-tandem mass spectroscopy. The ultrahigh performance liquid chromatography-tandem mass spectroscopy method was applied to various batches of leaves harvested on several dates from plants grown at two locations (Brazil and Germany). In addition, press juices prepared from plants cultivated in Germany and Brazil were analysed. The total bufadienolide content ranged from 16.28 to 40.50 mg/100 g dry weight in leaves from plants grown in Brazil. The total content of these four bufadienolides was significantly lower in plants cultivated in Germany (3.78–12.49 mg/100 g dry weight, resp.). The total amounts of bufadienolides were 0.091–0.163 mg/100 mL and 0.89–1.16 mg/100 mL in press juices obtained from plants cultivated in Germany and Brazil, respectively. When analysing single leaves from individual plants, the content of bufadienolides was markedly higher in young leaves. For comparative purposes, the content of these bufadienolides was also determined in Bryophyllum daigremontianum and Bryophyllum tubiflorum. Bersaldegenin-1,3,5-orthoacetate (4) was predominant in the leaves of B. daigremontianum and in the stems of B. tubiflorum, while the leaves of B. tubiflorum contained very low amounts of 14.

* Dedicated to Professor Dr. Dr. h. c. mult. Adolf Nahrstedt on the occasion of his 75th birthday.


Supporting Information

 
  • References

  • 1 Yadav NP, Dixit VK. Hepatoprotective activity of leaves of Kalanchoe pinnata Pers. J Ethnopharmacol 2003; 86: 197-202
  • 2 Ajibesin KK. Ethnobotanical survey of plants used for skin diseases and related ailments in Akwa Ibom State, Nigeria. Ethnobot Res Appl 2012; 10: 463-522
  • 3 Ghasi S, Egwuibe C, Achukwu PU, Onyeanusi JC. Assessment of the medical benefit in the folkloric use of Bryophyllum Pinnatum leaf among the Igbos of Nigeria for the treatment of hypertension. Afr J Pharm Pharmacol 2011; 5: 83-92
  • 4 Lans CA. Ethnomedicines used in Trinidad and Tobago for urinary problems and diabetes mellitus. J Ethnobiol Ethnomed 2006; 2: 45
  • 5 Daems W, Kaufmann H, Titze O. Kurzgefasste Bryophyllum-Chronologie. Weleda Korrespondenzblätter für Ärzte 1982; 105: 5-11
  • 6 Hassauer W, Schreiber K, von der Decken D. Bryophyllum – Ein neuer Weg in der tokolytischen Therapie. Erfahrungsheilkunde 1985; 34: 683-687
  • 7 Plangger N, Rist L, Zimmermann R, von Mandach U. Intravenous tocolysis with Bryophyllum pinnatum is better tolerated than beta-agonist application. Eur J Obstet Gynecol Reprod Biol 2006; 124: 168-172
  • 8 Simões-Wüst AP, Grãos M, Duarte CB, Brenneisen R, Hamburger M, Mennet M, Ramos MH, Schnelle M, Wächter R, Worel AM, von Mandach U. Juice of Bryophyllum pinnatum (Lam.) inhibits oxytocin-induced increase of the intracellular calcium concentration in human myometrial cells. Phytomedicine 2010; 17: 980-986
  • 9 Wächter R, Brenneisen R, Hamburger M, Mennet M, Schnelle M, Worel AM, Simoes-Wust AP, von Mandach U. Leaf press juice from Bryophyllum pinnatum (Lamarck) Oken induces myometrial relaxation. Phytomedicine 2011; 19: 74-82
  • 10 Schuler V, Suter K, Fürer K, Eberli D, Horst M, Betschart C, Brenneisen R, Hamburger M, Mennet M, Schnelle M, Simões-Wüst AP, von Mandach U. Bryophyllum pinnatum inhibits detrusor contractility in porcine bladder strips – a pharmacological study towards a new treatment option of overactive bladder. Phytomedicine 2012; 19: 947-951
  • 11 Betschart C, von Mandach U, Seifert B, Scheiner D, Perucchini D, Fink D, Geissbuhler V. Randomized, double-blind placebo-controlled trial with Bryophyllum pinnatum versus placebo for the treatment of overactive bladder in postmenopausal women. Phytomedicine 2013; 20: 351-358
  • 12 Fürer K, Eberli D, Betschart C, Brenneisen R, De Mieri M, Hamburger M, Mennet-von Eiff M, Potterat O, Schnelle M, Simões-Wüst AP, von Mandach U. Inhibition of porcine destrusor contractibility by the flavonoid fraction of Bryophyllum pinnatum – a potential phytotherapeutic drug for the treatment of the overactive bladder syndrome. Phytomedicine 2015; 22: 158-164
  • 13 Fürer K, Raith M, Brenneisen R, Mennet M, Simões-Wüst P, von Mandach U, Hamburger M, Potterat O. Two new flavonol glycosides and a metabolic profile of Bryophyllum pinnatum, a phytotherapeutic used in obstetrics and gynaecology. Planta Med 2013; 79: 1565-1571
  • 14 Wagner H, Lotter H, Fischer M. Die toxischen und sedierend wirkenden Bufadienolide von Kalanchoe daigremontiana Hamet et Perr. Helv Chim Acta 1986; 69: 359-367
  • 15 McKenzie RA, Franke FP, Dunster PJ. The toxicity to cattle and bufadienolide content of six Bryophyllum species. Austr Vet J 1987; 64: 298-301
  • 16 Knittel DN, Stintzing FC, Kammerer DR. Simultaneous determination of bufadienolides and phenolic compounds in sea squill (Drimia maritima (L.) Stearn) by HPLC-DAD-MSn as a means to differentiate individual plant parts and developmental stages. Anal Bioanal Chem 2014; 406: 6035-6050
  • 17 Ye M, Guo H, Guo H, Han J, Guo D. Simultaneous determination of cytotoxic bufadienolides in the Chinese medicine ChanSu by high-performance liquid chromatography coupled with photodiode array and mass spectrometry detections. J Chromatogr B 2006; 838: 86-95
  • 18 Xu W, Luo H, Zhang Y, Shan L, Li H, Yang M, Liu R, Zhang W. Simultaneous determination of five main active bufadienolides of Chan Su in rat plasma by liquid chromatography tandem mass spectrometry. J Chromatogr B 2007; 859: 157-163
  • 19 Huang H, Yang Y, Lv C, Chang W, Peng C, Wang S, Ge G, Han L, Zhang W, Liu R. Pharmacokinetics and tissue distribution of five bufadienolides from the Shexiang Baoxin pill following oral administration to mice. J Ethnopharmacol 2015; 161: 175-185
  • 20 Guidance for Industry: Bioanalytical Method Validation. US Food and Drug administration (FDA). Center for Drug Evaluation and Research. May 2001.
  • 21 Guideline on bioanalytical method validation. European Medicines Agency (EMEA/CHMP/EWP/192217/2009). London, 21 July 2011.
  • 22 Huang HH, Lin MK, Yang HL, Hseu YC, Liaw CC, Tseng YH, Tsuzuki M, Kuo YM. Cardenolides and bufadienolide glycosides from Kalanchoe tubiflora and evaluation of cytotoxicity. Planta Med 2013; 79: 1362-1369
  • 23 Capon RJ, MacLeod JK. Structure elucidation of a new bufadienolide toxin from the flowers of Bryophyllum tubiflorum Harv. (Crassulaceae). J Chem Res 1985; 52: 1071-1079
  • 24 Supratman U, Fujita T, Akiyama K, Hayashi H. Insecticidal compounds from Kalanchoe daigremontiana x tubiflora . Phytochemistry 2001; 58: 311-314
  • 25 Bardenes-Perez FR, Gershenzon J, Heckel DG. Insect attraction versus plant defense: young leaves high in glucosinolates stimulate oviposition by a specialist herbivore despite poor larval survival due to high saponin content. PLoS One 2014; 9: e95766
  • 26 Potter D, Kimmerer T. Inhibition of herbivory on young holly leaves: evidence for the defensive role of saponins. Oecologia 1989; 78: 322-329
  • 27 Fischer R, Nitzan N, Chaimovitsch D, Rubin B, Dudai N. Variation in essential oil composition within individual leaves of sweet basil (Ocimum basilicum L.) is more affected by leaf position than by age. J Agric Food Chem 2011; 59: 4913-4922
  • 28 Benthin B, Danz H, Hamburger M. Pressurized liquid extraction (PLE) of medicinal plants. J Chromatogr A 1999; 837: 211-219
  • 29 Basalo C, Mohn T, Hamburger M. Are extraction methods in quantitative assays of pharmacopoeia monographs exhaustive? A comparison with pressurized liquid extraction. Planta Med 2006; 72: 1157-1162
  • 30 Lambrigger-Steiner C, Simoes-Wüst AP, Kuck A, Fürer K, Hamburger M, von Mandach U. Sleep quality in pregnancy during treatment with Bryophyllum pinnatum: an observational study. Phytomedicine 2014; 21: 753-757